Pharmesis International Ltd. (SGX: BFK)
Health Care · Pharmaceuticals · SG
S$0.10
— today · -77.1% 1Y
Pharmesis International Ltd. (SGX: BFK) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.36M.
Over the last twelve months the share price has lost 77.1%, trading between 0.08 and 0.45.
Tweenvest scores Pharmesis International Ltd. across four factors: quality 58/100, value 51/100, growth 0/100. Its strongest factor is quality.
BFK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.36M
- Revenue (TTM)
- $4.18M
- P/E
- —
- EPS
- -0.23
- Dividend yield
- —
- Beta (5Y)
- -1.13
- 52-week high
- S$0.45
- 52-week low
- S$0.08
- Avg volume (3M)
- —
- Shares outstanding
- 31.70M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cai Lay Veterinary Pharmaceutical Joint Stock CompanyHNX: MKV | $2.54M | ₫13,200.00 | +10.00% |
| Double Bond Pharmaceutical International AB (publ)XSAT: DBP B | $2.51M | Skr0.11 | +3.70% |
| Jaguar Health, Inc.NasdaqCM: JAGX | $2.49M | $4.56 | -4.80% |
| Société des Industries Pharmaceutiques de Tunisie - S.A.BVMT: SIPHA | $2.38M | DT3.97 | -12.56% |
| Ishita Drugs and Industries LimitedBSE: 524400 | $2.35M | Rs76.00 | -0.26% |
| Hamps Bio LimitedBSE: 544312 | $2.30M | Rs25.50 | +0.24% |
| BioVaxys Technology Corp.CNSX: BIOV | $2.27M | CA$— | — |
| Cannabis Strategic VenturesOTCPK: NUGS | $1.97M | $0.00 | -30.99% |
Figures last refreshed Oct 11, 2026.